Newer Rheumatoid Arthritis Drug, Upadacitinib (Rinvoq), May Help Ease Tough-to-Treat Cases

MONDAY, Oct. 19, 2020 -- A recently approved rheumatoid arthritis medication appears to be an effective second-line therapy when biologic treatments start to fail, a new clinical trial reports. Arthritis sufferers treated with upadacitinib had a...
Source: Drugs.com - Daily MedNews - Category: General Medicine Source Type: news